XML 35 R25.htm IDEA: XBRL DOCUMENT
v3.24.3

Note 19 - Concentrations | 9 Months Ended
--- | ---
Sep. 30, 2024
Notes to Financial Statements |
Concentration Risk Disclosure [Text Block] | Note 19. Concentrations e-Commerce Operations concentrations: Customers: Sales to customers through Amazon accounted for 35.8% and 49.1% of the Company’s revenues during the nine months ended September 30, 2024 and 2023, respectively. No other customer accounted for 10% or more of the Company’s revenues for either period. Suppliers: The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s purchases for the three and nine months ended September 30, 2024 and 2023 (in thousands):
|  | For the Three Months Ended September 30, |
|  | 2024 |  |  | 2023 |
|  | Amount |  |  | % of Total Purchases |  |  | Amount |  |  | % of Total Purchases |
Iridium Satellite |  | $ | 378 |  |  |  | 14.5 | % |  | $ | — |  |  |  | — | %
Garmin |  | $ | 373 |  |  |  | 14.3 | % |  | $ | 444 |  |  |  | 23.2 | %
Globalstar |  | $ | 280 |  |  |  | 10.8 | % |  | $ | 186 |  |  |  | 9.7 | %
Maklink |  | $ | 264 |  |  |  | 10.1 | % |  | $ | — |  |  |  | — | %
|  | For the Nine Months Ended September 30, |
|  | 2024 |  |  | 2023 |
|  | Amount |  |  | % of Total Purchases |  |  | Amount |  |  | % of Total Purchases |
Iridium Satellite |  | $ | 1,314 |  |  |  | 18.1 | % |  | $ | 798 |  |  |  | 12.0 | %
Garmin |  | $ | 867 |  |  |  | 12.0 | % |  | $ | 1,494 |  |  |  | 22.5 | %
Globalstar |  | $ | 754 |  |  |  | 10.4 | % |  | $ | 706 |  |  |  | 10.6 | %
Geographic: The following table sets forth revenue as to each geographic location (in thousands):
|  | For the Three Months Ended September 30, |
|  | 2024 |  |  | 2023 |
|  | Amount |  |  | % of Total |  |  | Amount |  |  | % of Total |
Europe |  | $ | 2,018 |  |  |  | 52.6 | % |  | $ | 1,715 |  |  |  | 58.5 | %
North America |  |  | 1,349 |  |  |  | 35.2 | % |  |  | 737 |  |  |  | 25.1 | %
South America |  |  | 10 |  |  |  | 0.3 | % |  |  | 432 |  |  |  | 14.7 | %
Asia and Pacific |  |  | 429 |  |  |  | 11.2 | % |  |  | 24 |  |  |  | 0.8 | %
Africa |  |  | 28 |  |  |  | 0.7 | % |  |  | 23 |  |  |  | 0.8 | %
|  | $ | 3,834 |  |  |  | 100 | % |  | $ | 2,931 |  |  |  | 100 | %
|  | For the Nine Months Ended September 30, |
|  | 2024 |  |  | 2023 |
|  | Amount |  |  | % of Total |  |  | Amount |  |  | % of Total |
Europe |  | $ | 5,434 |  |  |  | 53.2 | % |  | $ | 5,382 |  |  |  | 61.4 | %
North America |  |  | 2,894 |  |  |  | 28.3 | % |  |  | 2,194 |  |  |  | 25.0 | %
South America |  |  | 41 |  |  |  | 0.4 | % |  |  | 1,026 |  |  |  | 11.7 | %
Asia and Pacific |  |  | 1,275 |  |  |  | 12.5 | % |  |  | 121 |  |  |  | 1.4 | %
Africa |  |  | 566 |  |  |  | 5.5 | % |  |  | 41 |  |  |  | 0.5 | %
|  | $ | 10,210 |  |  |  | 100 | % |  | $ | 8,764 |  |  |  | 100 | %
Healthcare operations concentrations: Suppliers: Progressive Care had significant concentrations with one vendor. The purchases from this significant vendor were 98.0% of total vendor purchases for the nine months ended September 30, 2024. Customers: Progressive Care trade receivables are primarily from prescription medications billed to various insurance providers. Ultimately, the insured is responsible for payment should the insurance company not reimburse Progressive Care. Progressive Care derives a significant portion of sales from prescription drug sales reimbursed through prescription drug plans administered by PBM companies. Prescription reimbursements from our three most significant PBMs were as follows:
|  | Nine Months Ended September 30, 2024 |
A |  |  | 29 | %
B |  |  | 25 | %
C |  |  | 11 | %

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/275/tableOfContent + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration